Detalhe da pesquisa
1.
HIV Diagnostics and Vaccines: It Takes Two to Tango.
J Infect Dis
; 2024 Mar 07.
Artigo
Inglês
| MEDLINE | ID: mdl-38451247
2.
Analysis of the HIV Vaccine Trials Network 702 Phase 2b-3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk.
J Infect Dis
; 226(2): 246-257, 2022 08 24.
Artigo
Inglês
| MEDLINE | ID: mdl-35758878
3.
The quest for vaccine-induced immune correlates of protection against tuberculosis.
Vaccine Insights
; 1(3): 165-181, 2022 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-37091190
4.
Magnitude and breadth of a nonprotective neutralizing antibody response in an efficacy trial of a candidate HIV-1 gp120 vaccine.
J Infect Dis
; 202(4): 595-605, 2010 Aug 15.
Artigo
Inglês
| MEDLINE | ID: mdl-20608874
5.
Poststudy Point-of-Care Oral Fluid Testing in Human Immunodeficiency Virus-1 Vaccinees.
Open Forum Infect Dis
; 8(1): ofaa606, 2021 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-33511233
6.
Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120.
PLoS One
; 12(11): e0185959, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-29149197
7.
Standardization of cytokine flow cytometry assays.
BMC Immunol
; 6: 13, 2005 Jun 24.
Artigo
Inglês
| MEDLINE | ID: mdl-15978127
8.
"In vitro systems to characterize the immune response to HIV-1 and HIV-1 vaccine candidates", NIAID Workshop Report, Bethesda, August 4, 2010.
Vaccine
; 29(29-30): 4647-53, 2011 Jun 24.
Artigo
Inglês
| MEDLINE | ID: mdl-21571022
9.
Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines.
J Virol
; 79(16): 10103-7, 2005 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-16051803